Sarepta Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SRPT and other ETFs, options, and stocks.About SRPT
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
SRPT Key Statistics
SRPT News
Leerink Partners analyst Joseph Schwartz has reiterated their bullish stance on SRPT stock, giving a Buy rating yesterday. Joseph Schwartz has given his Buy ra...
In March, Sarepta Therapeutics, Inc. SRPT shared an update on Elevidys (delandistrogene moxeparvovec-rokl), the only approved gene therapy in patients with Duch...
RBC Capital keeps a Sector Perform rating on Sarepta (SRPT) after the company’s partner Roche (RHHBY) announced the European Medicines Agency imposed clinical h...
Analyst ratings
83%
of 23 ratingsMore SRPT News
Deutsche Bank analyst David Hoang lowered the firm’s price target on Sarepta (SRPT) to $70 from $99 and keeps a Hold rating on the shares ahead of the Q1 report...
It is hard to get excited after looking at Sarepta Therapeutics' (NASDAQ:SRPT) recent performance, when its stock has declined 49% over the past three months. H...
Biotech stocks took a hit after the sudden resignation of Dr. Peter Marks, head of the FDA’s Center for Biologics Evaluation and Research (CBER). Shares of Mode...